jnj-56022473
Showing 1 - 2 of 2
Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) Trial in France, Germany (drug, procedure, other, genetic)
Terminated
- Myelodysplastic Syndrome (MDS)
- Acute Myeloid Leukemia (AML)
- JNJ-56022473
- +8 more
-
Nantes, France
- +9 more
Oct 23, 2018
Lupus Erythematosus, Systemic Trial in Berlin, Hannover, Mainz (JNJ-56022473, Placebo)
Withdrawn
- Lupus Erythematosus, Systemic
- JNJ-56022473
- Placebo
-
Berlin, Germany
- +2 more
Nov 23, 2017